Ultragenyx Pharmaceutical Inc.（RARE）内部人交易：高管与董事近期交易
过去 18 个月，共有 15 位内部人为 Ultragenyx Pharmaceutical Inc.（RARE）报告了 65 笔 Form 4 交易（最近一笔 2026-09-15）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-15 | Huizenga Theodore Alan | SVP, Chief Accounting Officer | 卖出 | 1,283 | $17,410 |
| 2026-09-08 | Huizenga Theodore Alan | SVP, Chief Accounting Officer | 卖出 | 161 | $2,252 |
| 2026-08-04 | Parschauer Karah Herdman | EVP and Chief Legal Officer | 卖出 | 1,900 | $47,348 |
| 2026-08-04 | Horn Howard | Chief Financial Officer | 卖出 | 4,696 | $117,024 |
| 2026-07-06 | Horn Howard | Chief Financial Officer | 卖出 | 4,698 | $155,645 |
| 2026-06-15 | Parschauer Karah Herdman | EVP and Chief Legal Officer | 卖出 | 1,899 | $46,753 |
| 2026-06-15 | Sanders Corazon (Corsee) D. | 董事 | 卖出 | 2,000 | $50,100 |
| 2026-06-01 | Horn Howard | Chief Financial Officer | 卖出 | 4,653 | $110,602 |
| 2026-05-18 | SULIMAN SHEHNAAZ | 董事 | 买入 | 7,751 | $0 |
| 2026-05-18 | WELCH DANIEL G | 董事 | 买入 | 7,751 | $0 |
| 2026-05-18 | Dunsire Deborah | 董事 | 买入 | 7,751 | $0 |
| 2026-05-18 | Ray Amrit | 董事 | 买入 | 7,751 | $0 |
| 2026-05-18 | Fust Matthew K | 董事 | 买入 | 7,751 | $0 |
| 2026-05-18 | SULIMAN SHEHNAAZ | 董事 | 卖出 | 5,740 | $144,189 |
| 2026-05-18 | Sanders Corazon (Corsee) D. | 董事 | 买入 | 7,751 | $0 |
| 2026-05-18 | NARACHI MICHAEL | 董事 | 买入 | 7,751 | $0 |
| 2026-05-06 | Crombez Eric | EVP and Chief Medical Officer | 卖出 | 344 | $8,586 |
| 2026-05-04 | Horn Howard | Chief Financial Officer | 卖出 | 4,683 | $116,607 |
| 2026-04-24 | Huizenga Theodore Alan | SVP, Chief Accounting Officer | 买入 | 20,241 | $0 |
| 2026-04-20 | Pinion John Richard | EVP, Chief Quality Operations Officer | 买入 | 23,116 | $0 |
| 2026-04-20 | Horn Howard | Chief Financial Officer | 买入 | 34,674 | $0 |
| 2026-04-20 | Crombez Eric | EVP and Chief Medical Officer | 买入 | 34,674 | $0 |
| 2026-04-20 | Huang Dennis Karl | EVP, Chief Technical Operations Officer | 买入 | 23,116 | $0 |
| 2026-04-20 | Parschauer Karah Herdman | EVP and Chief Legal Officer | 买入 | 28,895 | $0 |
| 2026-04-20 | Harris Erik | EVP & Chief Commercial Officer | 买入 | 28,895 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-15